Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1226 participants.
Also called NCT02808767
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,226 participants
- Registry
-
NCT02808767
-
- Other papers using this trial's data
- 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Completed
Technical summary
Registry record NCT02808767. Randomized; single masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2016-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction
- Acronym
- PRAGUE-18
- Condition
- Myocardial Infarction
- Condition
- Angioplasty, Balloon, Coronary
- Condition
- Platelet Aggregation Inhibitors
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Faculty Hospital Kralovske Vinohrady
Record details
- Record id
cardio:ct-nct02808767- Content hash
0cb0ed64ab0b9f6e137905751633e301c0669d8a8eeea4fea399ec9a88817be7